Kui Jiang
Director
Oncology
Dalian Medical University
China
Biography
1988~1993 bachelor of Dalian Medical University,1999~2002 master of Dalian Medical University
Research Interest
cancer chemotherapy;
Publications
-
Jumonji AT-rich interactive domain 1B over expression is associated with the development and progression of glioma , Liping Fang, Jiuhan Zhao, Dan Wang, Liyu Zhu, Jian Wang, Kui Jiang Int J Mol Med. 2016 July; 38(1): 172–182. Published online 2016 May 30. doi: 10.3892/ijmm.2016.2614
-
P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth，Oncotarget，2016 Vol. 7, No. 12，15135-15149，Xiaokun Gang1,2,*, Yinhui Yang2,3,*, Jian Zhong2, Kui Jiang2,4, Yunqian Pan2, R. Jeffrey Karnes5, Jun Zhang6, Wanhai Xu3, Guixia Wang1, Haojie Huang2,5,7
-
Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L Oncotarget, 2015 Vol. 6, No. 32 33279-89 Chengli Song 1,* , Qiang Xu 1,* , Kui Jiang 1 , Guangyu Zhou 1 , Xuebin Yu 1 , Lina Wang 1 ,Yuting Zhu 1 , Liping Fang 1 , Zhe Yu 1 , Jiing-Dwan Lee 2 , Shi-Cang Yu 3 , Qingkai Yang 1
